CPH
DGX icon

C Partners Holding’s Quest Diagnostics DGX Stock Holding History

C Partners Holding’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,088
Closed -$117K – 75
2018
Q3 		$117K Sell
1,088
-1,059
-49% -$116K 0.04% 160
2018
Q2 		$236K Buy
2,147
+42
+2% +$4.38K 0.09% 97
2018
Q1 		$211K Sell
2,105
-693
-25% -$71K 0.09% 152
2017
Q4 		$276K Buy
+2,798
New +$265K 0.11% 120

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

C Partners Holding's DGX Position: Q4 2018 in Review

C Partners Holding sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 1,088 shares — an estimated $117K sold.

C Partners Holding first reported a position in DGX in Q4 2017 and held it in 4 quarters. The position peaked at $276K in Q4 2017. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • C Partners Holding reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,088 Quest Diagnostics shares in Q4 2018, an estimated $117K.
  • C Partners Holding first reported a position in Quest Diagnostics in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's Quest Diagnostics position peaked at $276K in Q4 2017.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.